AVNRT Management
For acute AVNRT termination in hemodynamically stable patients, start with vagal maneuvers (particularly the modified Valsalva technique), followed by adenosine 6 mg IV rapid push if vagal maneuvers fail, then IV calcium channel blockers (diltiazem or verapamil) or beta-blockers as third-line, with catheter ablation of the slow pathway as the definitive long-term solution. 1, 2, 3
Acute Management Algorithm
First-Line: Vagal Maneuvers
- Perform vagal maneuvers with the patient in the supine position as the initial intervention 4, 1, 2
- The modified Valsalva maneuver is 2.8-3.8 times more effective than the standard technique 2, 3
- Have the patient bear down against a closed glottis for 10-30 seconds, generating intrathoracic pressure of at least 30-40 mmHg 4, 2
- Carotid sinus massage is an alternative but less effective option; apply steady pressure over the carotid sinus for 5-10 seconds after confirming absence of bruits by auscultation 4, 2
- Overall success rate of vagal maneuvers is approximately 27.7%, with Valsalva being more successful than carotid massage 4
Second-Line: Adenosine
- Administer adenosine 6 mg as a rapid IV push through a large vein, followed immediately by saline flush 2, 3
- Adenosine terminates AVNRT in approximately 90-95% of patients 4, 3
- Have cardioversion equipment ready during administration due to potential for transient arrhythmias 3, 5
- Adenosine works by inhibiting calcium influx through slow channels in the AV node, interrupting the reentrant circuit 4, 5
Critical Safety Point: Ensure the rhythm is truly AVNRT before administering adenosine or calcium channel blockers, as these agents can be dangerous in ventricular tachycardia or pre-excited atrial fibrillation 1, 2
Third-Line: IV Calcium Channel Blockers or Beta-Blockers
- IV diltiazem or verapamil achieve 80-98% success rates in resistant cases 2, 3
- Verapamil works by inhibiting calcium influx through slow channels, slowing AV conduction and prolonging the effective refractory period within the AV node 6
- Administer verapamil 5-10 mg IV, which produces peak therapeutic effects within 3-5 minutes 6
- Beta-blockers (esmolol, metoprolol) are less effective than calcium channel blockers but have an excellent safety profile 3
- Avoid calcium channel blockers in patients with severe conduction abnormalities, sinus node dysfunction, or acute decompensated heart failure 4, 6
Hemodynamically Unstable Patients
Long-Term Management Options
Definitive Therapy: Catheter Ablation
- Catheter ablation of the slow pathway is the first-line definitive treatment with a success rate of 94.3-98.5% 1, 3
- Slow pathway ablation is preferred over fast pathway ablation due to lower risk of AV block 3
- Ablation is potentially curative and eliminates the need for chronic pharmacological therapy 3
- Radiofrequency energy is applied at sites showing discrete slow potentials in the perinodal region 7
Pharmacological Prophylaxis (For Patients Not Pursuing Ablation)
- Oral verapamil or diltiazem are first-line pharmacological options 1, 3
- Oral beta-blockers are effective alternatives 1
- Other options include digitalis and class Ia, Ic, and III antiarrhythmic agents 8
- Avoid beta-blockers in patients with severe conduction abnormalities or sinus node dysfunction 1
Important Clinical Considerations
Transition to Maintenance Therapy
- Transition to oral antiarrhythmic agents is generally safe within 3 hours after acute treatment 9
- Options include oral digoxin, calcium channel blockers, beta-blockers, or class I antiarrhythmics 9
Common Pitfalls to Avoid
- Never administer verapamil or diltiazem to patients with pre-excited atrial fibrillation—these patients require immediate cardioversion 2
- Do not use calcium channel blockers in patients with severe heart failure (pulmonary wedge pressure >20 mmHg, ejection fraction <30%) as acute worsening may occur 6
- Avoid applying pressure to the eyeball as a vagal maneuver—this practice is potentially dangerous and has been abandoned 4